disorders of lipid metabolism	are characterized by	abnormal lipid levels
disorders of lipid metabolism	include	hyperlipidemia
disorders of lipid metabolism	lead to	atherosclerosis
disorders of lipid metabolism	increase	cardiovascular risk
hyperlipidemia	associated with	obesity
hyperlipidemia	associated with	diabetes
hyperlipidemia	increases	coronary artery disease
familial hypercholesterolemia	caused by	LDL receptor defect
familial hypercholesterolemia	caused by	APOB mutation
familial combined hyperlipidemia	characterized by	elevated LDL and VLDL
familial dysbetalipoproteinemia	caused by	APOE mutation
LPL deficiency	causes	hypertriglyceridemia
apolipoprotein E	influences	lipid transport
dysbetalipoproteinemia	features	elevated cholesterol and triglycerides
hypertriglyceridemia	leads to	pancreatitis
insulin resistance	contributes to	dyslipidemia
obesity	contributes to	dyslipidemia
hypothyroidism	causes	hyperlipidemia
nephrotic syndrome	causes	hyperlipidemia
diabetes mellitus	leads to	dyslipidemia
metabolic syndrome	includes	dyslipidemia
pancreatitis	is associated with	hypertriglyceridemia
xanthomas	occur with	hyperlipidemia
coronary artery disease	results from	dyslipidemia
atherosclerosis	involves	lipid accumulation
lipid panel	evaluates	lipid levels
lipoprotein(a)	increases	atherosclerotic risk
apolipoprotein B	indicates	atherogenic particle number
LDL receptor	mediates	LDL uptake
LDL cholesterol	drives	atherosclerotic plaque formation
HDL cholesterol	protects against	atherosclerosis
non-HDL cholesterol	predicts	cardiovascular risk
apoB-containing particles	increase	atherogenic risk
CETP	modifies	HDL composition
statins	reduce	LDL cholesterol
statins	improve	lipid profile
fibrates	reduce	triglycerides
omega-3 fatty acids	lower	triglycerides
bile acid sequestrants	lower	LDL cholesterol
niacin	raise	HDL cholesterol
PCSK9 inhibitors	lower	LDL cholesterol
ezetimibe	inhibit	intestinal cholesterol absorption
dietary modification	reduce	LDL cholesterol
physical activity	increases	HDL cholesterol
weight loss	improves	lipid profile
genetic factors	influence	lipid levels
age	increases	cardiovascular risk
smoking	worsens	lipid profile
alcohol consumption	increases	triglycerides
liver disease	alters	lipid metabolism
thyroid disease	affects	lipid levels
hormonal changes	affect	lipid levels
thiazide diuretics	raise	cholesterol
beta-blockers	worsen	lipid profile
dietary saturated fat	increases	LDL cholesterol
trans fats	raise	LDL cholesterol
polyunsaturated fats	lower	triglycerides
monounsaturated fats	improve	lipid profile
liver X receptor	regulates	cholesterol metabolism
lipoprotein lipase	deficiency leads to	hypertriglyceridemia
apoA-II	associates with	HDL particles
HDL particles	participate in	reverse cholesterol transport
LDL particle	binds to	LDL receptor
PCSK9	promotes degradation of	LDL receptor
apoB-100	is necessary for	LDL assembly
LDL assembly	requires	apoB-100
remnant clearance	involves	apoE
liver	synthesizes	cholesterol
intestine	absorbs	cholesterol
cholesterol	is transported by	LDL
cholesterol	is transported by	HDL
VLDL	carries	triglycerides
lipoprotein lipase	hydrolyzes	triglycerides in chylomicrons
LPL deficiency	leads to	hypertriglyceridemia
chylomicrons	form	in intestine
apoB-containing lipoproteins	are	atherogenic
HDL	mediates	reverse cholesterol transport
reverse cholesterol transport	reduces	cholesterol accumulation
Lp(a)	is an	independent risk factor
LDL particle	carries	cholesterol
HDL	carries	cholesterol away from arteries
apoB-100	constitutes	LDL particle
apoB-containing lipoproteins	are	atherogenic
apoE variants	influence	lipid phenotype
HDL maturation	requires	ApoA1
Apolipoprotein E variants	influence	lipid phenotype
liver	regulates	cholesterol homeostasis
intestinal cholesterol absorption	is inhibited by	ezetimibe
bile acids	derived from	cholesterol
cholesterol synthesis	occurs in	liver
cholesterol transport	occurs via	lipoproteins
HDL	participates in	reverse cholesterol transport
LDL receptor	expression	downregulated by	PCSK9
PCSK9	downregulates	LDL receptor
Apolipoprotein B-100	is required for	LDL assembly
LDL assembly	requires	apoB-100
remnant clearance	involves	apoE
VLDL	carries	triglycerides
lipoprotein lipase	hydrolyzes	triglycerides in chylomicrons
chylomicrons	deliver	triglycerides to tissues
apoA1	is major apolipoprotein of	HDL
apoA1 deficiency	reduces	HDL
chylomicron remnants	cleared by	liver
bile acids	regulate	cholesterol homeostasis
statins	block	HMG-CoA reductase
HMG-CoA reductase	target of	statins
CYP7A1	controls	bile acid synthesis
bile acid sequestrants	increase	bile acid excretion
omega-3 fatty acids	reduce	hepatic VLDL production
dietary saturated fat	raises	LDL cholesterol
trans fatty acids	increase	LDL cholesterol
dietary fiber	lowers	cholesterol absorption
physical activity	lowers	triglycerides
weight loss	lowers	triglycerides
smoking cessation	lowers	lipid risk
obesity	increases	triglycerides
diabetes	worsens	dyslipidemia
nephrotic syndrome	increases	ApoB-containing lipoproteins
lipid abnormalities	inform	risk stratification
